CLINICAL_TRIALS
research
· 2011-10-14
Clinical Trial Update: Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus [Phase 3]
Summary
A Phase 3 clinical trial evaluating high-dose Symlin (pramlintide) for Type 2 Diabetes Mellitus; the current status of the trial is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cheryl Rosenfeld, DO | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: UNKNOWN